PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+20.2%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$4.36B
AUM Growth
+$4.36B
(+23%)
Cap. Flow
+$460M
Cap. Flow
% of AUM
10.56%
Top 10 Holdings %
Top 10 Hldgs %
53.12%
Holding
126
New
23
Increased
23
Reduced
17
Closed
18
Top Buys
| 1 |
BridgeBio Pharma
BBIO
|
$181M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$179M |
| 3 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$90.3M |
| 4 |
NVRO
NEVRO CORP.
NVRO
|
$46.7M |
| 5 |
Zymeworks
ZYME
|
$39.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$148M |
| 2 |
Ascendis Pharma
ASND
|
$73.7M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$19.5M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$17.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$16.4M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Financials | 0.76% |
| 3 | Technology | 0.14% |
| 4 | Consumer Discretionary | 0.02% |
